Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2019, Article ID 1897237, 12 pages
https://doi.org/10.1155/2019/1897237
Research Article

High Carbohydrate High Fat Diet Induced Hepatic Steatosis and Dyslipidemia Were Ameliorated by Psidium guajava Leaf Powder Supplementation in Rats

Department of Pharmaceutical Sciences, North South University, Bangladesh

Correspondence should be addressed to Md Ashraful Alam; moc.oohay@nugailanos and Nusrat Subhan; moc.oohay@40immir

Received 30 September 2018; Revised 15 November 2018; Accepted 27 December 2018; Published 3 February 2019

Academic Editor: Evan P. Cherniack

Copyright © 2019 Md. Abdullah Al Mamun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Bhurosy and R. Jeewon, “Overweight and obesity epidemic in developing countries: a problem with diet, physical activity, or socioeconomic status?” The Scientific World Journal, vol. 2014, Article ID 964236, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Hruby and F. B. Hu, “The Epidemiology of Obesity: A Big Picture,” PharmacoEconomics, vol. 33, no. 7, pp. 673–689, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. P. G. Kopelman, “Obesity as a medical problem,” Nature, vol. 404, no. 6778, pp. 635–643, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Hainer, H. Zamrazilová, J. Spálová et al., “Role of hereditary factors in weight loss and its maintenance,” Physiological Research, vol. 57, no. 1, pp. S1–S15, 2008. View at Google Scholar · View at Scopus
  5. B. Sivertsen, S. Krokstad, S. Øverland, and A. Mykletun, “The epidemiology of insomnia: Associations with physical and mental health. The HUNT-2 study,” Journal of Psychosomatic Research, vol. 67, no. 2, pp. 109–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Uretsky, F. H. Messerli, S. Bangalore et al., “Obesity paradox in patients with hypertension and coronary artery disease,” American Journal of Medicine, vol. 120, no. 10, pp. 863–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. E. Bays, J. M. Gonzalez-Campoy, G. A. Bray et al., “Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity,” Expert Review of Cardiovascular Therapy, vol. 6, no. 3, pp. 343–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Dobbins, L. S. Szczepaniak, B. Bentley, V. Esser, J. Myhill, and J. McGarry, “Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats,” Diabetes, vol. 50, no. 1, pp. 123–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Adams II, T. Pratipanawatr, R. Berria et al., “Ceramide content is increased in skeletal muscle from obese insulin-resistant humans,” Diabetes, vol. 53, no. 1, pp. 25–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Mitrakou, D. Kelley, T. Veneman et al., “Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM,” Diabetes, vol. 39, no. 11, pp. 1381–1390, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. D. B. Savage, K. F. Petersen, and G. I. Shulman, “Disordered lipid metabolism and the pathogenesis of insulin resistance,” Physiological Reviews, vol. 87, no. 2, pp. 507–520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. T. Samuel and G. I. Shulman, “Mechanisms for insulin resistance: common threads and missing links,” Cell, vol. 148, no. 5, pp. 852–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Steneberg, N. Rubins, R. Bartoov-Shifman, M. D. Walker, and H. Edlund, “The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse,” Cell Metabolism, vol. 1, no. 4, pp. 245–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Wei, D. Wang, F. Topczewski, and M. J. Pagliassotti, “Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells,” American Journal of Physiology-Endocrinology and Metabolism, vol. 291, no. 2, pp. E275–E281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Karaçor, M. Çam, N. Orhan, E. Coşgun, and H. Demirin, “High fatty diet effects on rat liver,” European Journal of General Medicine, vol. 11, no. 2, pp. 99–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. W. Iwu, A. R. Duncan, and C. O. Okunji, “New antimicrobials of plant origin,” in Perspectives on new crops and new uses ASHS Press, pp. 457–462, ASHS Press, Alexandria, Va, USA, 1999. View at Google Scholar
  19. E. A. Palombo, “Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function,” Phytotherapy Research, vol. 20, no. 9, pp. 717–724, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. S. Bansode and M. Chavan, “Screening of Guava (Psidium gaujava) for Effective Phytomedicines and Study on its Antimicrobial effect against Selected Enteric Pathogens,” International Journal of Advances InPharmacy, Biology And Chemistry, vol. 3, no. 3, 2014. View at Google Scholar
  21. B. Joseph and R. M. Priya, “Review on nutritional, medicinal and pharmacological properties of Guava (Psidium guajava Linn.),” International Journal of Pharma and Bio Sciences, vol. 2, no. 1, pp. 53–69, 2011. View at Google Scholar · View at Scopus
  22. R. M. Gutiérrez, S. Mitchell, and R. V. Solis, “Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology,” Journal of Ethnopharmacology, vol. 117, no. 1, pp. 1–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-C. Chen, C.-L. Hsieh, K.-D. Huang, Y.-B. Ker, C.-C. Chyau, and R. Y. Peng, “Anticancer activity of rhamnoallosan against DU-145 cells is kinetically complementary to coexisting polyphenolics in psidium guajava budding leaves,” Journal of Agricultural and Food Chemistry, vol. 57, no. 14, pp. 6114–6122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Adam, I. Vahirua-Lechat, E. Deslandes, and C. Menut, “Aromatic plants of french polynesia. V. Chemical composition of essential oils of leaves of psidium guajava l. And psidium cattleyanum sabine,” Journal of Essential Oil Research, vol. 23, no. 1, pp. 98–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Rahman, M. N. Alam, A. Ulla et al., “Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats,” Lipids in Health and Disease, vol. 16, no. 1, p. 151, 2017. View at Google Scholar · View at Scopus
  26. A. Ulla, M. A. Alam, B. Sikder et al., “Supplementation of Syzygium cumini seed powder prevented obesity, glucose intolerance, hyperlipidemia and oxidative stress in high carbohydrate high fat diet induced obese rats,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 289, 2017. View at Google Scholar · View at Scopus
  27. W. G. Niehaus Jr. and B. Samuelsson, “Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation,” European Journal of Biochemistry, vol. 6, no. 1, pp. 126–130, 1968. View at Publisher · View at Google Scholar · View at Scopus
  28. W. R. Tracey, J. Tse, and G. Carter, “Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors,” The Journal of Pharmacology and Experimental Therapeutics, vol. 272, no. 3, pp. 1011–1015, 1995. View at Google Scholar · View at Scopus
  29. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. B. K. Tiwari, D. Kumar, A. B. Abidi, and S. I. Rizvi, “Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats,” ISRN Pharmacology, vol. 2014, Article ID 608590, 7 pages, 2014. View at Publisher · View at Google Scholar
  31. R. A. Khan, “Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl4-induced oxidative stress in the thyroid tissue of rats,” BMC Complementary and Alternative Medicine, vol. 12, p. 181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.,” The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  33. D. J. Jollow, J. R. Mitchell, N. Zampaglione, and J. R. Gillette, “Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite,” Pharmacology, vol. 11, no. 3, pp. 151–169, 1974. View at Publisher · View at Google Scholar · View at Scopus
  34. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, “Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker,” Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206–209, 1982. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Matsuzawa, T. Funahashi, and T. Nakamura, “Molecular mechanism of Metabolic Syndrome X: Contribution of adipocytokines·adipocyte-derived bioactive substances,” Annals of the New York Academy of Sciences, vol. 892, pp. 146–154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. P. E. Scherer, “Adipose tissue,” Diabetes, vol. 55, no. 6, pp. 1537–1545, 2006. View at Google Scholar
  37. S. Bais, G. S. Singh, and R. Sharma, “Antiobesity and Hypolipidemic Activity of Moringa oleifera Leaves against High Fat Diet-Induced Obesity in Rats,” Advances in Biology, vol. 2014, Article ID 162914, 9 pages, 2014. View at Publisher · View at Google Scholar
  38. H. Fang and F. Beier, “Mouse models of osteoarthritis: Modelling risk factors and assessing outcomes,” Nature Reviews Rheumatology, vol. 10, no. 7, pp. 413–421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. K. A. Sanda, H. A. Grema, Y. A. Geidam, and Y. M. Bukar-Kolo, “Pharmacological aspects of Psidium guajava: An Update,” International Journal of Pharmacology, vol. 7, no. 3, pp. 316–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Shakeera Banu, K. Sujatha, G. Sridharan, and R. Manikandan, “Antihyperglycemic and antihyperlipidemic potentials of Psidium guajava in alloxan-induced diabetic rats,” Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 2, pp. 88-89, 2013. View at Google Scholar · View at Scopus
  41. J. A. O. Ojewole, “Hypoglycemic and hypotensive effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 27, no. 10, pp. 689–695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Alam, K. Kauter, and L. Brown, “Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats,” Nutrients, vol. 5, no. 3, pp. 637–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Alam, N. Subhan, H. Hossain et al., “Hydroxycinnamic acid derivatives: A potential class of natural compounds for the management of lipid metabolism and obesity,” Journal of Nutrition and Metabolism, vol. 13, no. 1, p. 27, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. Alam, N. Subhan, M. M. Rahman, S. J. Uddin, H. M. Reza, and S. D. Sarker, “Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action,” Advances in Nutrition, vol. 5, no. 4, pp. 404–417, 2014. View at Publisher · View at Google Scholar
  45. S. M. Grundy, “Obesity, metabolic syndrome, and cardiovascular disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2595–2600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. N. V. da Cunha, P. Pinge-Filho, C. Panis et al., “Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 306, no. 10, pp. H1472–H1480, 2014. View at Publisher · View at Google Scholar
  47. A. Fernández-Sánchez, E. Madrigal-Santillán, M. Bautista et al., “Inflammation, oxidative stress, and obesity,” International Journal of Molecular Sciences, vol. 12, no. 5, pp. 3117–3132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. A. Philippe, R. G. Ruddeli, and G. A. Ramm, “Role of iron in hepatic fibrosis: One piece in the puzzle,” World Journal of Gastroenterology, vol. 13, no. 35, pp. 4746–4754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. B. D. Maliken, J. E. Nelson, H. M. Klintworth, M. Beauchamp, M. M. Yeh, and K. V. Kowdley, “Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease,” Hepatology, vol. 57, no. 5, pp. 1806–1813, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. M. M. Rahman, S. Zaman, F. Mamun et al., “Phenolic content analysis in Psidium guajava leaves powder by HPLC-DAD system and in vivo renoprotective and antioxidant activities in fludrocortisone acetate-induced rats,” Journal of Food Biochemistry, vol. 42, no. 6, article e12687, 2018. View at Publisher · View at Google Scholar
  51. G. Ö. Elpek, “Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7260–7276, 2014. View at Publisher · View at Google Scholar · View at Scopus